Thomas M. Jeitner

2.6k total citations
58 papers, 2.0k citations indexed

About

Thomas M. Jeitner is a scholar working on Biochemistry, Molecular Biology and Oncology. According to data from OpenAlex, Thomas M. Jeitner has authored 58 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Biochemistry, 17 papers in Molecular Biology and 11 papers in Oncology. Recurrent topics in Thomas M. Jeitner's work include Amino Acid Enzymes and Metabolism (12 papers), Blood properties and coagulation (9 papers) and Genetic Neurodegenerative Diseases (8 papers). Thomas M. Jeitner is often cited by papers focused on Amino Acid Enzymes and Metabolism (12 papers), Blood properties and coagulation (9 papers) and Genetic Neurodegenerative Diseases (8 papers). Thomas M. Jeitner collaborates with scholars based in United States, Australia and Germany. Thomas M. Jeitner's co-authors include Arthur J.L. Cooper, Edward J. Delikatny, John P. Blass, Boris F. Krasnikov, Peter M. Steinert, Soo‐Youl Kim, John T. Pinto, Wayne R. Matson, M. Flint Beal and Hui Xu and has published in prestigious journals such as Journal of Neuroscience, The Journal of Immunology and Analytical Biochemistry.

In The Last Decade

Thomas M. Jeitner

58 papers receiving 2.0k citations

Peers

Countries citing papers authored by Thomas M. Jeitner

Since Specialization

Citations

This map shows the geographic impact of Thomas M. Jeitner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas M. Jeitner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas M. Jeitner more than expected).

Fields of papers citing papers by Thomas M. Jeitner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas M. Jeitner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas M. Jeitner. The network helps show where Thomas M. Jeitner may publish in the future.

Co-authorship network of co-authors of Thomas M. Jeitner

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas M. Jeitner. A scholar is included among the top collaborators of Thomas M. Jeitner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas M. Jeitner. Thomas M. Jeitner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	2-[18F]Fluoropropionic Acid PET Imaging of Doxorubicin-Induced Cardiotoxicity 2025 ·Molecular Imaging and Biology ·(unknown), (unknown), Chulhee Lee, Edward K. Fung, Thomas M. Jeitner, (unknown), Annarita Di Lorenzo, John W. Babich, Alejandro Amor‐Coarasa, James M. Kelly	2
2	Stabilization of guinea pig transglutaminase 2 solutions 2022 ·Analytical Biochemistry ·Thomas M. Jeitner, James M. Kelly	1
3	Cystamine and cysteamine as inhibitors of transglutaminase activity in vivo 2018 ·Bioscience Reports ·Thomas M. Jeitner, John T. Pinto, Arthur J.L. Cooper	38
4	Linking Inflammation and Parkinson Disease: Hypochlorous Acid Generates Parkinsonian Poisons 2016 ·Toxicological Sciences ·Thomas M. Jeitner, (unknown), Boris F. Krasnikov, (unknown), Morgan R. Peltier, Graham R. Moran	64
5	Inflaming the diseased brain: a role for tainted melanins 2015 ·Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease ·Thomas M. Jeitner, (unknown), Patricia A. Patrick, Irving H. Gomolin, Thomas Palaia, Louis Ragolia, Donald A. Brand, Edward J. Delikatny	11
6	Critical Evaluation of the Changes in Glutamine Synthetase Activity in Models of Cerebral Stroke 2015 ·Neurochemical Research ·Thomas M. Jeitner, K.P. Battaile, Arthur J.L. Cooper	31
7	Preparation of 2-nitro-5-thiobenzoate for the routine determination of reagent hypochlorous acid concentrations 2013 ·Analytical Biochemistry ·Thomas M. Jeitner, (unknown), (unknown)	4
8	Donepezil Dosing Strategies: Pharmacokinetic Considerations 2011 ·Journal of the American Medical Directors Association ·Irving H. Gomolin, Candace Smith, Thomas M. Jeitner	8
9	Cholinesterase Inhibitors: Applying Pharmacokinetics to Clinical Decision Making 2011 ·The American journal of geriatric pharmacotherapy ·Irving H. Gomolin, Candace Smith, Thomas M. Jeitner	4
10	Increased levels of γ‐glutamylamines in Huntington disease CSF 2008 ·Journal of Neurochemistry ·Thomas M. Jeitner, Wayne R. Matson, John E. Folk, John P. Blass, Arthur J.L. Cooper	44
11	Inhibition of the α‐ketoglutarate dehydrogenase complex by the myeloperoxidase products, hypochlorous acid and mono‐N‐chloramine 2005 ·Journal of Neurochemistry ·Thomas M. Jeitner, Hui Xu, Gary E. Gibson	51
12	Mechanism for the inhibition of transglutaminase 2 by cystamine 2005 ·Biochemical Pharmacology ·Thomas M. Jeitner, Edward J. Delikatny, Jenny Ahlqvist, (unknown), Arthur J.L. Cooper	87
13	Oxidative stress increases internal calcium stores and reduces a key mitochondrial enzyme 2002 ·Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease ·Gary E. Gibson, Hui Zhang, Hui Xu, Larry C.H. Park, Thomas M. Jeitner	43
14	Cross linking of polyglutamine domains catalyzed by tissue transglutaminase is greatly favored with pathological-length repeats: does transglutaminase activity play a role in (CAG)n/Qn-expansion diseases? 2002 ·Neurochemistry International ·Arthur J.L. Cooper, Thomas M. Jeitner, Vittorio Gentile, John P. Blass	59
15	Mechanisms for the Cytotoxicity of Cysteamine 2001 ·Toxicological Sciences ·Thomas M. Jeitner	65
16	N^ε‐(γ‐l‐Glutamyl)‐l‐lysine (GGEL) is increased in cerebrospinal fluid of patients with Huntington's disease 2001 ·Journal of Neurochemistry ·Thomas M. Jeitner, (unknown), Wayne R. Matson, Yevgeny Daikhin, Marc Yudkoff, John E. Folk, Lawrence Steinman, Susan Browne, M. Flint Beal, John P. Blass, Arthur J.L. Cooper	72
17	Inhibition of Drug-Naive and -Resistant Leukemia Cell Proliferation by Low Molecular Weight Thiols 1998 ·Biochemical Pharmacology ·Thomas M. Jeitner, Edward J. Delikatny, (unknown), (unknown), Nicholas H. Hunt	17
18	Inhibition of the proliferation of human neural neoplastic cell lines by cysteamine 1996 ·Cancer Letters ·Thomas M. Jeitner, (unknown)	11
19	Transcription factors as targets for oxidative signalling during lymphocyte activation 1995 ·Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression ·Sherilyn Goldstone, (unknown), Thomas M. Jeitner, Nicholas H. Hunt	50
20	Effect of cysteamine on the lysosomal enzymes of the hyperprolactinaemic rat pituitary 1990 ·Journal of Endocrinology ·Thomas M. Jeitner, J. R. Oliver	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact